Literature DB >> 16862167

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

P Reddy1, K Johnson, J P Uberti, C Reynolds, S Silver, L Ayash, T M Braun, V Ratanatharathorn.   

Abstract

Chronic graft-versus-host disease (cGVHD) is the most common late complication of allogeneic hematopoietic cell transplantation (HCT) causing significant morbidity and mortality. The kidneys are not considered a target organ for cGVHD in humans, although animal models show renal damage. Renal involvement in patients with cGVHD, presenting as nephrotic syndrome (NS), has rarely been reported in patients who received allogeneic transplantation. Herein we describe, by far, the largest series of nine patients with NS associated with cGVHD, including two patients who received a reduced-intensity regimen. Pathological features of membranous nephropathy were the most common finding on renal biopsy. The clinical course of the NS was temporally associated with the classical features of cGVHD in all but one of the nine cases. The clinicopathologic features of NS in our series as well as reports in the literature demonstrate an immunopathologic process typical of antibody-mediated damage consistent with cGVHD. Treatment directed against antibody-mediated damage, such as anti-B-cell antibody may play an important role in ameliorating NS associated with cGVHD.

Entities:  

Mesh:

Year:  2006        PMID: 16862167     DOI: 10.1038/sj.bmt.1705446

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  24 in total

1.  Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.

Authors:  B Dhakal; A Singavi; E P Cohen; M Dangal; J Palmer; A Dall; A D'Souza; M Hamadani; P N Hari
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

2.  Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience.

Authors:  QiaoYuan Wu; XiaoHong Li; YongRong Lai; ZhiGang Peng; YunHua Liao
Journal:  Int Urol Nephrol       Date:  2014-03-26       Impact factor: 2.370

3.  Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.

Authors:  Kei Ohnuma; Ryo Hatano; Thomas M Aune; Haruna Otsuka; Satoshi Iwata; Nam H Dang; Taketo Yamada; Chikao Morimoto
Journal:  J Immunol       Date:  2015-03-18       Impact factor: 5.422

Review 4.  Renal dysfunction following bone marrow transplantation.

Authors:  Stephan Kemmner; Mareike Verbeek; Uwe Heemann
Journal:  J Nephrol       Date:  2016-09-02       Impact factor: 3.902

5.  Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.

Authors:  Brian T Brinkerhoff; Donald C Houghton; Megan L Troxell
Journal:  Mod Pathol       Date:  2016-03-25       Impact factor: 7.842

Review 6.  Chronic kidney disease after hematopoietic stem cell transplantation.

Authors:  Eric P Cohen; Priya Pais; John E Moulder
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

7.  Long-term remission of HSCT-related NS after a second allogenic stem cell transplant.

Authors:  Shogo Kobayashi; Yukihiko Kawasaki; Hideki Sano; Kazuhiro Mochizuki; Mitsuaki Hosoya; Atsushi Kikuta
Journal:  Pediatr Nephrol       Date:  2015-12-11       Impact factor: 3.714

Review 8.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

9.  A boy with membranous nephropathy after allogeneic bone marrow transplantation.

Authors:  Osamu Motoyama; Yumiko Uchino; Mika Tokuyama; Kikuo Iitaka; Akira Ohara
Journal:  Clin Exp Nephrol       Date:  2009-05-09       Impact factor: 2.801

10.  Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.

Authors:  Claudia Fofi; Simona Barberi; Antonella Stoppacciaro; Giorgio Punzo; Paolo Menè
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.